Trials / Withdrawn
WithdrawnNCT04427228
Single vs Multi-fraction SRS Patients on Immunotherapy
MIGRAINE: Randomized trIal of Single Versus Multifraction Radiosurgery on Immunotherapy
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is meant to compare different surgical approaches to brain cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiosurgery Single Treatment | Frameless single-fraction SRS. One large treatment done on each brain tumor. 20 Gy for GTVs (or resection cavity CTVs) \< 2 cm, and 18 Gy for GTVs (or resection cavity CTVs) between 2-3 cm in the single-fraction. |
| RADIATION | Radiosurgery Three Treatments | Multi-fraction SRS. Three small doses done on each brain tumor. 27 Gy in 3 fractions in the multi-fraction group |
Timeline
- Start date
- 2020-06-29
- Primary completion
- 2022-12-12
- Completion
- 2022-12-12
- First posted
- 2020-06-11
- Last updated
- 2023-08-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04427228. Inclusion in this directory is not an endorsement.